帮助 关于我们

返回检索结果

吡格列酮、二甲双胍对2型糖尿病合并非酒精性脂肪肝患者血清视黄醇结合蛋白4、脂联素水平的影响比较
Effect of Piglitazone and Metformin on Retinol-binding Protein-4 and Adiponcetin in Patients with Type 2 Diabetes Mellitus Complicated with Non-alcohol Fatty Acid Liver Diseases

查看参考文献7篇

文摘 目的比较吡格列酮和二甲双胍对2型糖尿病(T2DM)合并非酒精性脂肪肝(NAFLD)患者血清视黄醇结合蛋白-4(RBP-4)和脂联素(APN)水平的影响。方法将60例T2DM合并NAFLD患者随机分为吡格列酮组和二甲双胍组,在治疗前、后12周测定患者血生化指标、血清RBP-4和APN水平,并进行比较。结果治疗12周后,两组患者的体重指数、空腹血糖、胰岛素抵抗指数(HOMA-IR)、GHbA_(1C)、空腹胰岛素(FIns)和三酰甘油水平均较治疗前显著降低(P均<0.05),APN水平较治疗前显著增高(P均<0.05)。吡格列酮组RBP-4水平较治疗前下降显著(P<0.05),二甲双胍组RBP-4水平与治疗前相比差异无统计学意义(P>0.05)。吡格列酮组的RBP-4、FIns和HOMA-IR水平明显低于二甲双胍组(P均<0.05),BMI水平明显高于二甲双胍组(P<0.05)。结论对于T2DM合并NAFLD的患者,吡格列酮在降低脂肪炎症因子RBP-4、改善胰岛素抵抗方面的效果优于二甲双胍。
其他语种文摘 Objective To compare the effects of piglitazone and metformin on retinol-binding protein-4(RBP-4) and adiponcetin (APN) in patients with type 2 diabetes mellitus (T2DM) complicated with Non alcohol fatty acid liver disease (NAFLD). Methods Totally 60 T2DM patients complicated with NAFLD were equally and randomly divided into pioglitazone group and metform group. The levels of biochemical indicators including body mass index (BMI),glucose hemoglobin A_(1C)(GHbA_(1C)),insulin resistance (HOMA-IR),fasting blood glucose (FBG),fasting insulin (FIns),and serum triglycerides (TG) as well as serum RBP-4 and APN level were measured pre-treatment and 12 weeks after treatments. Results After 12 weeks of treaments, BMI,FBG,HOMA-IR,GHbA_(1C),FIns,and TG decreased (all P < 0. 05) in both piglitazone group and metform group. APN increased (all P < 0. 05) in both groups. RBP-4 decreased (P < 0. 05) in piglitazone group. Compare with the metform group,the levels of RBP-4,FIns,and HOMA-IR decreased and BMI increased in piglitazone group (P < 0. 05). Conclusion Piglitazone is superior to metoform in decreasing RBP-4 level and HOMA-IR in patients with T2DM complicated with NAFLD.
来源 中国医学科学院学报 ,2014,36(3):309-312 【核心库】
DOI 10.3881/j.issn.1000-503x.2014.03.015
关键词 2型糖尿病 ; 非酒精性脂肪肝 ; 吡格列酮 ; 二甲双胍 ; 血清视黄醇结合蛋白-4 ; 脂联素
地址

杭州师范大学附属医院内分泌科, 杭州, 310015

语种 中文
文献类型 研究性论文
ISSN 1000-503X
学科 内科学
文献收藏号 CSCD:5231891

参考文献 共 7 共1页

1.  Yang W. Prevalence of diabetes among men and women in China. New Engl J Med,2010,362(12):1090-1101 被引 1552    
2.  李焱. 2型糖尿病、动脉粥样硬化与炎症. 中华内分泌代谢杂志,2005,21(6):6S1-6S3 被引 1    
3.  颜红梅. 非酒精性脂肪肝与代谢综合征关系的研究. 中国糖尿病杂志,2006,14(5):326-328 被引 16    
4.  闫焱. 住院2型糖尿病患者肝脏疾病谱调查及非酒精性脂肪性肝病相关危险因素分析. 中华医学杂志,2013,93(4):270-274 被引 8    
5.  中华医学会内分泌学会肝病与代谢学组(筹). 中华医学会内分泌学分会"非酒精性脂肪性肝病与相关代谢紊乱诊疗共识". 中华内分泌代谢杂志,2010,26(7):531-534 被引 3    
6.  Coletta D K. Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial. Diabetologia,2009,52(4):723-732 被引 6    
7.  Zulia A. In vitro and in vivo effects of metformin on human adipose tissue adiponectin. Obesity facts,2011,4(1):27-33 被引 2    
引证文献 1

1 逄琪琪 达格列净或吡格列酮联合二甲双胍治疗2型糖尿病合并非酒精性脂肪性肝病的疗效比较 中国新药与临床杂志,2020,39(11):675-679
被引 0 次

显示所有1篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护:中国科学院文献情报中心
地址:北京中关村北四环西路33号 邮政编码:100190 联系电话:(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号